Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 173

Similar articles for PubMed (Select 21060077)

1.

ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF; ACCF/ACG/AHA.

Circulation. 2010 Dec 14;122(24):2619-33. doi: 10.1161/CIR.0b013e318202f701. Epub 2010 Nov 8. Review. No abstract available.

2.

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF; ACCF/ACG/AHA.

Am J Gastroenterol. 2010 Dec;105(12):2533-49. doi: 10.1038/ajg.2010.445. Review. No abstract available.

PMID:
21131924
3.

ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.

Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, Mahaffey KW, Quigley EM, Scheiman J, Sperling LS, Tomaselli GF; ACCF/ACG/AHA.

J Am Coll Cardiol. 2010 Dec 7;56(24):2051-66. doi: 10.1016/j.jacc.2010.09.010. No abstract available.

4.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. No abstract available.

5.

[Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions].

Würtz M, Grove EL.

Ugeskr Laeger. 2013 Sep 9;175(37):2094-8. Review. Danish.

PMID:
24011204
6.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Circulation. 2008 Oct 28;118(18):1894-909. doi: 10.1161/CIRCULATIONAHA.108.191087. Epub 2008 Oct 3. No abstract available. Erratum in: Circulation. 2010 Aug 24;122(8):e438.

7.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation; American College of Gastroenterology; American Heart Association.

Am J Gastroenterol. 2008 Nov;103(11):2890-907. doi: 10.1111/j.1572-0241.2008.02216.x. Epub 2008 Oct 3. No abstract available.

PMID:
18853965
8.

Risk of combining PPIs with thienopyridines: fact or fiction?

Sibbing D, Kastrati A.

Lancet. 2009 Sep 19;374(9694):952-4. doi: 10.1016/S0140-6736(09)61562-2. Epub 2009 Aug 31. No abstract available.

PMID:
19726077
9.

The prevalence of co-administration of clopidogrel and proton pump inhibitors.

Shrestha K, Hughes JD, Lee YP, Parsons R.

Qual Prim Care. 2011;19(1):35-42.

PMID:
21703110
11.

ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association.

Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Writing Committee Members, Holmes DR Jr, Dehmer GJ, Kaul S, Leifer D, O'Gara PT, Stein CM.

Circulation. 2010 Aug 3;122(5):537-57. doi: 10.1161/CIR.0b013e3181ee08ed. Epub 2010 Jun 28. No abstract available.

12.
13.

Prasugrel: an efficacy and safety review of a new antiplatelet therapy option.

Armani AM.

Crit Pathw Cardiol. 2010 Dec;9(4):199-202. doi: 10.1097/HPC.0b013e3181fed221. Review.

PMID:
21119337
14.

NSAID-induced gastrointestinal and cardiovascular injury.

Ng SC, Chan FK.

Curr Opin Gastroenterol. 2010 Nov;26(6):611-7. doi: 10.1097/MOG.0b013e32833e91eb. Review.

PMID:
20948372
15.

Proton pump inhibitors and clopidogrel - hazardous drug interaction or hazardous interpretation of data?

Moayyedi P, Sadowski DC.

Can J Gastroenterol. 2009 Apr;23(4):251-2. No abstract available.

16.
17.

Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.

Tran M, Tafreshi J, Pai RG.

J Cardiovasc Pharmacol Ther. 2010 Dec;15(4):326-37. doi: 10.1177/1074248410369109. Epub 2010 Oct 11. Review.

PMID:
20938037
18.

New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.

Hsu PI.

J Gastroenterol Hepatol. 2012 Apr;27(4):654-61. doi: 10.1111/j.1440-1746.2012.07085.x.

PMID:
22283743
19.

Risk and benefit of proton pump inhibitor for patients undergoing anti-platelet therapy including clopidogrel.

Furuta T.

Intern Med. 2009;48(21):1847-8. Epub 2009 Nov 2. No abstract available.

20.

[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].

Casado-Arroyo R, Muñoz-Villalenguas M, Lanas Arbeloa A.

Gastroenterol Hepatol. 2011 Aug-Sep;34(7):478-91. doi: 10.1016/j.gastrohep.2011.04.002. Epub 2011 Jun 17. Review. Spanish.

PMID:
21684042
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk